제놀루션

225220KOSDAQ

58.4 / 100

Reference Date: 2026-09-08

Financial Score20.0 / 40

News Sentiment19.4 / 25

Momentum9.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Slightly up 3.6% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Genolux operates in the molecular diagnostic equipment and RNAi research sectors, offering automated nucleic acid extraction devices and RNA synthesis services. The company has developed the world's first RNAi-based treatment for foulbrood disease in bees and obtained product approval, while expanding its RNAi-based agricultural pest control technologies.

Number of Employees

76people

Average Salary

53.4M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 15.004.0Point

PBR

0.39Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE

-16.98Industry Average 8.000.0Point

Well below industry avg

Debt Ratio

0.44Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20251.0 / 10 points

Revenue Growth Rate

1.0 / 3

Avg ▲2.4% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼11.8% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -10.6% (declining, 3yr)

Detailed News Sentiment

6 totalPositive 5Neutral 1Negative 0Average Sentiment Score 77.5

Positive
제놀루션, 재능대와 업무협약…바이오·진단 전문 인재 양성
제놀루션과 재능대학교의 협약으로 바이오 및 진단 분야 전문 인재 양성이 촉진되어 기업의 기술 역량 강화에 긍정적 영향 예상.
Neutral
[사이언스샷] 멕시코, 세계 최초로 RNA 간섭 살균제 승인
Positive
제놀루션, 김민이 공동대표 자사주 매수 계획 공시
제놀루션의 공동대표 김민이 자사주 매수 계획을 공시하여 주주 신뢰도 향상과 기업 가치 상승 기대.

Detailed Momentum

52-week position3.0Point

52w lower range (23%)

Current 1,378Won52-week high 2,54052-week low 1,030

1-month return4.0Point

1m +3.61% (slight rise)

Volume trend2.0Point

Volume flat

Detailed Disclosure

11 totalPositive 0Neutral 11Negative 0

Neutral주식등의대량보유상황보고서(일반)2026-09-01
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-08-27
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-08-27
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-08-27
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-08-27